Skip to content

Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease

Effect of Simultaneous Dual Stimulation on Freezing of Gait in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02850159
Enrollment
32
Registered
2016-07-29
Start date
2013-09-30
Completion date
2015-11-30
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The purpose of this study is to investigate the effect of dual-mode non-invasive brain stimulation (NIBS) with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex compared with rTMS alone in patients with Parkinson's disease (PD) with freezing of gait (FOG).

Detailed description

Patients in the dual-mode group underwent five consecutive daily sessions of dual-mode NIBS with simultaneous high-frequency rTMS and tDCS, whereas patients in the rTMS group underwent high-frequency rTMS with sham tDCS. Assessments of FOG, motor, ambulatory and cognitive function were performed three times: at baseline before NIBS, immediately after NIBS, and one week after cessation of NIBS.

Interventions

DEVICErTMS and tDCS

Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously

DEVICErTMS

Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and sham anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed as Parkinson's disease (PD) with freezing of gait * walk independently without walking devices

Exclusion criteria

* pre-existing and active major neurological diseases other than PD * a previous history of seizures * implanted metallic objects that would contraindicate rTMS

Design outcomes

Primary

MeasureTime frameDescription
Change of Freezing of Gait Questionnaire (FOG-Q)Assessed at T0, pre-NIBS at day 1 and T1, immediately after NIBS at day 5Change of a self-assessment scale for evaluating participant freezing of gait (FOG) symptoms after non-invasive brain stimulation (NIBS) for 5 consecutive days ((freezing of gait questionnaire (FOG-Q) after NIBS) - (FOG-Q before NIBS) Minimum score: -5 Maximum score: 0 Lower values represent a better outcome.

Participant flow

Participants by arm

ArmCount
Dual-mode Group
the dual-mode NIBS with high-frequency rTMS and tDCS simultaneously rTMS and tDCS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
16
rTMS Group
high-frequency rTMS and sham tDCS rTMS: Patients underwent five consecutive daily sessions of dual-mode NIBS with high-frequency repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex of the lower leg and sham anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex simultaneously
16
Total32

Baseline characteristics

CharacteristicDual-mode GrouprTMS GroupTotal
Age, Continuous63.6 years
STANDARD_DEVIATION 7.5
63.8 years
STANDARD_DEVIATION 8.3
63.7 years
STANDARD_DEVIATION 7.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
16 Participants16 Participants32 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Korea, Republic of
16 participants16 participants32 participants
Right Handedness16 Participants16 Participants32 Participants
Sex: Female, Male
Female
7 Participants5 Participants12 Participants
Sex: Female, Male
Male
9 Participants11 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 16
other
Total, other adverse events
0 / 160 / 16
serious
Total, serious adverse events
0 / 160 / 16

Outcome results

Primary

Change of Freezing of Gait Questionnaire (FOG-Q)

Change of a self-assessment scale for evaluating participant freezing of gait (FOG) symptoms after non-invasive brain stimulation (NIBS) for 5 consecutive days ((freezing of gait questionnaire (FOG-Q) after NIBS) - (FOG-Q before NIBS) Minimum score: -5 Maximum score: 0 Lower values represent a better outcome.

Time frame: Assessed at T0, pre-NIBS at day 1 and T1, immediately after NIBS at day 5

ArmMeasureValue (MEAN)Dispersion
Dual-mode GroupChange of Freezing of Gait Questionnaire (FOG-Q)12.0 scoreStandard Deviation 5
rTMS GroupChange of Freezing of Gait Questionnaire (FOG-Q)13.9 scoreStandard Deviation 4.9

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026